Sarcoma Flashcards

1
Q

Define sarcoma

A
  • Sarcoma = malignant tumour of mesenchymal cells (i.e., of connective tissue)
    • OMA = BENIGN
    • SARCOMA = MALIGNANT
      ~~~

~~~

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name some examples of benign and malignant neoplasms of soft tissue origin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Briefly describe sarcomas

A
  • Malignant tumour of mesenchymal/connective tissues.
  • Rare in adults (~1%) but significant in paediatric/teenage malignancies (~15%).
  • Arise anywhere, often hidden deep in the limbs (has a predilection for joints and proximal limbs)
  • > 80 subtypes with distinct clinical characteristics, natural history, and biology
  • Distinct clinical characteristics, natural history and biology
    – Classified by tissue of origin +/- molecular genetic alteration
    – Classified as Bone or Soft Tissue sarcomas for Staging

Incidence of Subtypes Differs with Age:
- Typically in children/teens/young adults: Ewing sarcoma, Osteosarcoma, Rhabdomyosarcoma, Synovial Sarcoma.
- Typically in older adults: Angiosarcoma, Chondrosarcoma, Leiomyosarcoma, Liposarcoma, Malignant peripheral nerve sheath tumour, Synovial sarcoma, Undifferentiated pleomorphic sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List sarcoma risk factors

A
  • De-novo (no risk factors) = common. ^[vast majority are sporadic]
  • Inherited (rare)
    • Hereditary cancer syndromes (e.g., Li Fraumeni ^[germline cancer], Neurofibromatosis type 1)
    • Neurofibromatosis type 1 (NF1 gene mutation, malignant peripheral nerve sheath tumours [MPNST])
  • Acquired
    • External beam radiotherapy particularly at a young age ^[if angiosarcoma inquire about this]
      • Angiosarcoma, undifferentiated pleomorphic sarcoma, leiomyosarcoma and MPNST
    • Chronic lymphoedema eg after breast cancer surgery
      • Aggressive form of angiosarcoma (Stewart-Treves syndrome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the stem cell theory of cancer as it relates to sarcoma

A

STEM CELL THEORY OF CANCER: that many cancers form from malignant stem cells that choose a path of differentiation.

Neoplastic cells with stem cell properties are present within malignant neoplasms which makes them resistant to therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the two broad groups of sarcoma

A
  • Two major groups:
    • 2/3: complex unbalanced karyotype, with genomic instability and heterogeneous mutations between tumours of the same type
    • 1/3: disease-defining recurrent genetic alteration, specific translocation or characteristic point mutation i.e. every cell in the sarcoma has this aberration (eg synovial sarcoma, Ewing sarcoma, clear cell sarcoma)
  • Implications for therapy: Heterogeneous neoplasms have varied response to treatment, Advances in targeted therapies/inhibitors for specific gene fusions.

Note:
- tumours with translocations (where each cell has the same molecular aberration) are often composed of uniform/monotonous cells e.g. Ewing
- tumours with complex karyotypes are typically polymorphic e.g. dedifferentiated lipomyosarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the spectrum of connective tissue tumour behaviour

A
  • Spectrum from benign to malignant
    • benign (eg lipoma)
    • intermediate, locally aggressive (eg desmoid type fibromatosis)
    • intermediate, rarely metastasizing (eg giant cell tumour of soft tissue)
    • malignant (eg Ewing sarcoma)
  • Sarcomas usually spread via bloodstream (compared to carcinoma via lymphatic spread)
  • Grading reflects aggressiveness.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe sarcoma grading

A
  1. Tumour Differentiation: (1, 2, or 3 points based on how closely it resembles normal tissue)
  2. Mitotic Count: (1, 2, or 3 points based on how many mitoses per 10 high power fields)
  3. Tumour Necrosis: (0, 1, or 2 points if no necrosis, <50% or >50% necrosis)
  • Grade = Sum total of scores for differentiation, mitotic count, and necrosis
    • 2-3 points = Grade 1 (low grade)
    • 4-5 points = Grade 2 (intermediate grade)
    • 6-8 points = Grade 3 (high grade)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Compare and contrast sarcoma and carcinoma

A
  • Sarcoma
    • Arises from connective tissues (e.g., bone, cartilage, muscle, fat, nerve)
    • Rare
    • Usually haematogenous spread
    • Mostly affects children/young adults
  • Carcinoma
    • Arises from epithelial tissues (e.g., lung, breast, prostate, colon, skin)
    • Common
    • Usually lymphatic spread
    • Mostly affects people >50
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List the most common tymours in bone

A

Most Common Malignant Tumour in Bone?
- METASTASIS! (Breast, Lung, Kidney, Prostate, Thyroid)

Non Neoplastic Bone Conditions

  1. Cystic lesions in bone: Solitary bone cyst, Aneurysmal bone cyst
  2. Reactive bone lesions simulating tumours: Osteoid osteoma, Osteoblastoma, Non-osteogenic fibroma (metaphyseal fibrous defect), Giant cell granuloma
  3. Hamartomas of bone: Osteoma, Osteochondroma, Enchondroma (chondroma)
  4. Infection (osteomyelitis): Tuberculosis, Bacteria
  5. Malformation: Fibrous dysplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List some general facts about bonetumours

A

Bone Tumours: General Comments

  • Most common Primary malignancies arising in Bone:
    1. Myeloma ^[in elderly]
    2. Osteosarcoma
    3. Chondrosarcoma
  • Most common during time of active skeletal growth = younger age, up to 30yrs, M> F
  • Common in bones with highest growth rate i.e., Distal femur, proximal tibia
  • High-grade sarcomas can also arise in damaged bone (areas of infarction, chronic osteomyelitis, irradiation, or Paget’s disease) - especially in older adults
  • Some bone tumours are difficult to classify as benign or malignant (e.g., Giant Cell Tumour is locally aggressive and sometimes metastasizes) i.e. intermediate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Disntiguish between primary sarcomas of bone on the basis of age

A
  • <40 years: Osteosarcoma, Ewing sarcoma
  • >40 years: Chondrosarcoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List and briefly describe the essential information required for diagnosing bone tumours

A
  • Age: Skeletally immature vs mature
  • Location: Which bone? (Long bone, flat bone, digits, vertebra, craniofacial bones) and Which part of bone? (Epiphysis, Metaphysis, Diaphysis)
  • Radiology: CRITICAL
  • Biopsy:
    Pathologist should not diagnose a bone tumour without radiological correlation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe osteosarcoma

A

Definition
- Malignant tumour differentiating towards osteoblasts, with production of osteoid/bone

Epidemiology
- Most common bone sarcoma (35%)
- M:F = 2:1
- Usually in children/adolescents (during maximal bone growth); also in older adults

Etiology
- Most cases = Unknown
- Patients with retinoblastoma (Rb) gene mutations = several hundred-fold greater incidence
- Associated with conditions of high bone turnover, such as Paget’s disease and fibrous dysplasia of bone, also if prior radiotherapy or bone necrosis
- Older adults with osteosarcoma often have one of these predisposing conditions (= ‘secondary’ osteosarcoma)

Clinical Features
- Metaphysis (most often distal femur, proximal tibia)
- Localized pain and swelling or pathological fracture
- ~10-20% of patients have pulmonary metastases at diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe investigarions necessary for diagnosis and staging osteosarcomas

A
  • Imaging:
    • XR
    • CT: cortical irregularities/fracture sites/mineralisation
    • MRI: extension into soft tissue/marrow/joint space
    • PET scan: assess primary lesion; detect metastases elsewhere
    • Radionuclide bone scan.
  • Biochemistry: Elevated ALP ^[indicates osteoblast activity] + LDH ^[indicates high cell turnover].
  • Biopsy: Core or open (incisional) biopsy preferred - core limits risk of recurrence; FNA is inappropriate due to loss of architectural information.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the microscopic features of osteosarcoma

A

Compared to normal bone, osteosarcoma shows:
- Architecture: crowded/more cellular
- Cytology: Tumour cells often ‘spindle’ shaped, hyperchromatic, variable
- Pathognomonic feature = production of neoplastic osteoid/ matrix (appears pink due to lack of mineralisation)
- Often scanty, irregular/’lace-like’ & does not mineralize normally
- Tumor cells may also show predominantly fibrosarcomatous or chondrosarcomatous differentiation

17
Q

Distinguish between soft tissue sarcomas occurring in adults vs children

A

Soft tissue sarcomas by frequency:
Adult:
1. Liposarcoma
2. Leiomyosarcoma

Paediatric:
1. Rhabdomyosarcoma
2. Ewing sarcoma (of soft tissue)

18
Q

Describe WDLPS

A

Definition: Locally aggressive mesenchymal neoplasm with mature adipocytes and stromal cells showing focal nuclear atypia.

Epidemiology: Most common form of liposarcoma, affecting middle-aged to elderly adults.
- extremely rare in childhood
- Sex: M = F

Etiology: Unknown.
Molecularly characterized by ring or giant marker / rod chromosomes, with amplification of several genes including MDM2.

Clinical Features:

  • Location:
    - Deep thigh or other proximal limbs, retroperitoneum, trunk, spermatic cord, mediastinum
    - May also arise in subcutaneous tissue; rarely in skin (‘atypical lipomatous tumour’)
    - Less frequent in head/neck area
  • Slow-growing, painless, deep-seated mass
  • Retroperitoneal tumours may only be discovered after attaining significant growth (> 20 cm)
19
Q

List relevant investigations in WLDPS

A
  • MRI preferred for imaging.
  • Biopsy: Core, incisional, or excisional; FNA inappropriate.
20
Q

Describe treatment and prognosis

A

Treatment:
- Complete excision with negative margins often curative
- Surgical debulking for large, multifocal retroperitoneal/intra-abdominal tumours
- May require partial or complete resection of intraabdominal organs

Prognosis: Behaviour depends on location.
- Superficial locations more surgically amenable – can resect with negative margins
- In skin it’s called an ‘atypical lipomatous tumour’ (ALT)
- Deep locations (eg retroperitoneum) more difficult to resect – often recur locally – and can undergo ‘de-differentiation’ and subsequently metastasise
- No metastatic potential unless dedifferentiation is present

21
Q

Describe the macro and micro appearance of lipomyosarcoma

A

Macro:
- Well-circumscribed, lobular
- Cream/tan/grey, homogeneous cut surface
- Appears to arise from fat and bulge into muscle
- Thickened fibrous bands may be evident
- Fat necrosis may be seen in larger tumours (not pictured. Looks very pale yellow)

Micro:

Compared to normal fat, liposarcoma shows:
- Significant variation in size and shape of adipocytes
- Focal nuclear hyperchromasia and mild atypia
- Thickened, irregular fibrous bands/septa
- Often contain atypical spindle shaped cells
- Lipoblasts may be seen
* Multivacuolated
* Nucleus indented by the vacuoles
- Significant nuclear pleomorphism/atypia absent

22
Q

List and describe the ancillary tests for WDLPS

A

Immunohistochemistry: S100 protein (+) in adipocytes and lipoblasts

Cytogenetics:
- Characteristic supernumerary ring and giant marker chromosomes
- Contain amplified sequences from 12q14-15 region

Molecular tests:
- MDM2 gene amplification detected via fluorescent in situ hybridisation (FISH) - necessary to distinguish between it and lipoma